Quarterly Statement Of Cash Flows

Immuno-Biological Laboratories Co., Ltd. - Filing #7581667

Concept As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Quarterly statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
-41,810,000 JPY
-91,115,000 JPY
Interest and dividends received
84,000 JPY
30,000 JPY
Interest paid
-525,000 JPY
-239,000 JPY
Income taxes paid
-8,375,000 JPY
-8,178,000 JPY
Net cash provided by (used in) operating activities
-50,626,000 JPY
-99,503,000 JPY
Cash flows from investing activities
Loan advances
JPY
-10,000,000 JPY
Other, net
50,000 JPY
JPY
Net cash provided by (used in) investing activities
-63,950,000 JPY
-39,000,000 JPY
Cash flows from financing activities
Proceeds from long-term borrowings
JPY
40,000,000 JPY
Repayments of long-term borrowings
-2,004,000 JPY
-8,000,000 JPY
Other, net
0 JPY
JPY
Net cash provided by (used in) financing activities
2,995,000 JPY
132,000,000 JPY
Effect of exchange rate change on cash and cash equivalents
3,191,000 JPY
816,000 JPY
Net increase (decrease) in cash and cash equivalents
-108,389,000 JPY
-5,687,000 JPY
Cash and cash equivalents
340,795,000 JPY
449,184,000 JPY
546,335,000 JPY
552,022,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.